Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:1215-1218
Published online before print March 8, 2004, doi: 10.1161/01.CIR.0000121427.53291.78
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/10/1215    most recent
01.CIR.0000121427.53291.78v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higashi, Y.
Right arrow Articles by Yoshizumi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higashi, Y.
Right arrow Articles by Yoshizumi, M.
Related Collections
Right arrow Other arteriosclerosis
Right arrow Other Treatment

(Circulation. 2004;109:1215-1218.)
© 2004 American Heart Association, Inc.


Brief Rapid Communications

Autologous Bone-Marrow Mononuclear Cell Implantation Improves Endothelium-Dependent Vasodilation in Patients With Limb Ischemia

Yukihito Higashi, MD; Masashi Kimura, MD; Keiko Hara, MD; Kensuke Noma, MD; Daisuke Jitsuiki, MD; Keigo Nakagawa, MD; Tetsuya Oshima, MD; Kazuaki Chayama, MD; Taijiro Sueda, MD; Chikara Goto, RTP, MS; Hiroaki Matsubara, MD; Toyoaki Murohara, MD; Masao Yoshizumi, MD

From the Department of Cardiovascular Physiology and Medicine (Y.H., M.Y.), Department of Medicine and Molecular Science (M.K., K.H., K. Noma, D.J., K. Nakagawa, K.C.), Division of Physical Therapy, Institute of Health Sciences (C.G.), and the Department of Clinical Laboratory Medicine (T.O.), Department of Surgery (T.S.), Hiroshima University Graduate School of Biomedical Sciences, Department of Cardiovascular Medicine (H.M.), Kyoto Prefectural University of Medicine, and Department of Cardiology (T.M.), Nagoya University Graduate School of Medicine.

Correspondence to Yukihito Higashi, MD, PhD, FAHA, Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. E-mail yhigashi{at}hiroshima-u.ac.jp

Received March 5, 2003; de novo received December 15, 2003; revision received January 28, 2003; accepted January 28, 2003.

Background— Patients with limb ischemia were associated with endothelial dysfunction. The purpose of this study was to determine whether autologous bone-marrow mononuclear cell (BM-MNC) implantation improves endothelial dysfunction in patients with limb ischemia.

Methods and Results— We evaluated the leg blood flow (LBF) response to acetylcholine (ACh), an endothelium-dependent vasodilator, and sodium nitroprusside (SNP), an endothelium-independent vasodilator, before and after BM-MNC implantation in 7 patients with limb ischemia. LBF was measured with a mercury-filled Silastic strain-gauge plethysmograph. The number of BM-MNCs implanted into ischemic limbs was 1.6x109±0.3x109. The number of CD34+ cells included in the implanted BM-MNCs was 3.8x107±1.6x107. BM-MNC implantation improved the ankle-brachial pressure index (0.33±0.21 to 0.39±0.17, P=0.06), transcutaneous oxygen pressure (28.4±11.5 to 36.6±5.2 mm Hg, P=0.03), and pain-free walking time (0.8±0.6 to 2.9±2.2 minutes, P=0.02). After BM-MNC implantation, LBF response to ACh was enhanced (19.3±6.8 versus 29.6±7.1 mL/min per 100 mL; P=0.002). The vasodilatory effect of SNP was similar before and after BM-MNC implantation.

Conclusions— These findings suggest that BM-MNC implantation augments endothelium-dependent vasodilation in patients with limb ischemia.


Key Words: angiogenesis • cells • endothelium • ischemia




This article has been cited by other articles:


Home page
StrokeHome page
R. P.W. Rouhl, R. J. van Oostenbrugge, J. Damoiseaux, J.-W. C. Tervaert, and J. Lodder
Endothelial Progenitor Cell Research in Stroke: A Potential Shift in Pathophysiological and Therapeutical Concepts
Stroke, July 1, 2008; 39(7): 2158 - 2165.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
C Kalka and I. Baumgartner
Gene and stem cell therapy in peripheral arterial occlusive disease
Vascular Medicine, May 1, 2008; 13(2): 157 - 172.
[Abstract] [PDF]


Home page
Stem CellsHome page
H. Shao, Y. Tan, D. Eton, Z. Yang, M. G. Uberti, S. Li, A. Schulick, and H. Yu
Statin and Stromal Cell-Derived Factor-1 Additively Promote Angiogenesis by Enhancement of Progenitor Cells Incorporation into New Vessels
Stem Cells, May 1, 2008; 26(5): 1376 - 1384.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Kendziorra, H. Barthel, S. Erbs, F. Emmrich, R. Hambrecht, G. Schuler, O. Sabri, and R. Kluge
Effect of Progenitor Cells on Myocardial Perfusion and Metabolism in Patients After Recanalization of a Chronically Occluded Coronary Artery
J. Nucl. Med., April 1, 2008; 49(4): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
L. Cai, B. H. Johnstone, T. G. Cook, Z. Liang, D. Traktuev, K. Cornetta, D. A. Ingram, E. D. Rosen, and K. L. March
Suppression of Hepatocyte Growth Factor Production Impairs the Ability of Adipose-Derived Stem Cells to Promote Ischemic Tissue Revascularization
Stem Cells, December 1, 2007; 25(12): 3234 - 3243.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Hasegawa, T. Ogihara, T. Yamada, Y. Ishigaki, J. Imai, K. Uno, J. Gao, K. Kaneko, H. Ishihara, H. Sasano, et al.
Bone Marrow (BM) Transplantation Promotes {beta}-Cell Regeneration after Acute Injury through BM Cell Mobilization
Endocrinology, May 1, 2007; 148(5): 2006 - 2015.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Wassmann, N. Werner, T. Czech, and G. Nickenig
Improvement of Endothelial Function by Systemic Transfusion of Vascular Progenitor Cells
Circ. Res., October 13, 2006; 99(8): E74 - E83.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D.-I. Kim, M.-J. Kim, J.-H. Joh, S.-W. Shin, Y.-S. Do, J.-Y. Moon, N.-R. Kim, J.-E. Lim, A.-K. Kim, H.-S. Eo, et al.
Angiogenesis Facilitated by Autologous Whole Bone Marrow Stem Cell Transplantation for Buerger's Disease
Stem Cells, May 1, 2006; 24(5): 1194 - 1200.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
J. Emmerich
Current State and Perspective on Medical Treatment of Critical Leg Ischemia: Gene and Cell Therapy
International Journal of Lower Extremity Wounds, December 1, 2005; 4(4): 234 - 241.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Napoli, S. Williams-Ignarro, F. de Nigris, G. de Rosa, L. O. Lerman, B. Farzati, A. Matarazzo, G. Sica, C. Botti, A. Fiore, et al.
Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb
PNAS, November 22, 2005; 102(47): 17202 - 17206.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Erbs, A. Linke, V. Adams, K. Lenk, H. Thiele, K.-W. Diederich, F. Emmrich, R. Kluge, K. Kendziorra, O. Sabri, et al.
Transplantation of Blood-Derived Progenitor Cells After Recanalization of Chronic Coronary Artery Occlusion: First Randomized and Placebo-Controlled Study
Circ. Res., October 14, 2005; 97(8): 756 - 762.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Iwase, N. Nagaya, T. Fujii, T. Itoh, S. Murakami, T. Matsumoto, K. Kangawa, and S. Kitamura
Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia
Cardiovasc Res, June 1, 2005; 66(3): 543 - 551.
[Abstract] [Full Text] [PDF]